Patient Simulation Market

The patient simulation market is projected to reach USD 3.23 billion by 2030 from USD 1.54 billion in 2025, at a CAGR of 16.0% during the forecast period. The patient simulation market is experiencing significant growth, driven by the rising emphasis on patient safety and competency-based clinical training. Worldwide, approximately 1 in 10 patients sustains harm during healthcare delivery, with over 3 million deaths occurring annually due to unsafe care practices. Notably, more than half of these adverse events are considered preventable, with nearly half of preventable harm linked to medication errors (Source: WHO). These statistics are motivating healthcare organizations to improve clinical training programs through simulation-based education methods.

Some of the major players in the patient simulation market with a significant global presence include Surgical Science Sweden AB (Sweden), Laerdal Medical (Norway), Nasco Healthcare (US), Kyoto Kagaku (Japan), Limbs & Things (UK), Simulab Corporation (US), Medical-X (Netherlands), 3B Scientific (UK), and others. These companies have adopted various organic and inorganic strategies, such as collaborations, acquisitions, product launches, partnerships, agreements, and expansions, to strengthen their international presence and capture a larger share of the patient simulation market. These strategies have enabled the market to grow across different regions by offering coding solutions.

• In October 2025, Anatomage (US) launched a major update to its 3D interactive medical study platform, enhancing the visualization of real human anatomy and expanding clinical training capabilities for medical education.
• In February 2025, Surgical Science Sweden AB (Sweden) acquired Intelligent Ultrasound to strengthen its ultrasound simulation portfolio, expand its R&D capabilities, and enhance its global presence in medical training and patient safety solutions.

To know about the assumptions considered for the study download the pdf brochure

Laerdal Medical is a Norway-based company that provides patient simulation and medical training solutions focused on enhancing healthcare quality and patient safety. The company creates full-body simulators that mimic real human physiology for training in ICU, emergency, trauma, and resuscitation scenarios. Laerdal combines hardware manikins with scenario-based software, cloud-enabled performance tracking, and curriculum support to offer comprehensive simulation-based education programs. Its product range includes advanced simulation platforms and CPR training manikins, which are widely used by medical schools, nursing programs, hospitals, and emergency response teams worldwide.

Surgical Science Sweden AB is a Sweden-based medical simulation company dedicated to improving clinical skills and patient safety through cutting-edge training technologies. The company creates high-fidelity virtual reality (VR) simulators that allow healthcare professionals to practice minimally invasive and interventional procedures in a risk-free setting. Surgical Science incorporates its simulators into surgeon training programs to develop skills prior to real surgeries. Its product offerings include laparoscopic, endoscopic, robotic surgery, and ultrasound simulation platforms used by hospitals, academic institutions, and medical device manufacturers worldwide.

MARKET RANKING

Five major companies lead the competitive landscape of the patient simulation market: 3B Scientific (Germany), Laerdal Medical (Norway), Surgical Science Sweden AB (Sweden), Gaumard Scientific Co. (US), and Anatomage (US), shaping market evolution through differentiated strategies and sustained technology investment. These companies provide scalable solutions that support the patient simulation market with high-fidelity manikins, anatomical models, and advanced simulation platforms used for clinical, emergency, and medical education training worldwide.

Related Reports:

Patient Simulation Market by Offering (High-fidelity Simulator, Software, Web-based), Technology (AI-integrated), Age (Pediatric, Adults), Indication (Respiratory, Emergency, Cardio), End User (Academic Institutes, Hospital) - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com